Capital Research Global Investors
VCEL icon

Capital Research Global Investors’s Vericel Corp VCEL Stock Holding History

Capital Research Global Investors’s Portfolio VCEL Stock Details VCEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-853,668
Closed -$26.9M – 458
2025
Q3 		$26.9M Hold
853,668
– – 0.01% 392
2025
Q2 		$36.3M Buy
853,668
+199,207
+30% +$8.29M 0.01% 364
2025
Q1 		$29.2M Buy
+654,461
New +$35.2M 0.01% 386

Other funds holding VCEL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return

Capital Research Global Investors's VCEL Position: Q4 2025 in Review

Capital Research Global Investors sold out of Vericel Corp (VCEL) in Q4 2025, closing a stake of 853,668 shares — an estimated $26.9M sold.

Capital Research Global Investors first reported a position in VCEL in Q1 2025 and held it in 3 quarters. The position peaked at $36.3M in Q2 2025. 273 funds tracked by Wall St. Rank hold VCEL as of Q4 2025.

  • Capital Research Global Investors reported no remaining Vericel Corp position as of Q4 2025 after selling out during the quarter.
  • Capital Research Global Investors sold 853,668 Vericel Corp shares in Q4 2025, an estimated $26.9M.
  • Capital Research Global Investors first reported a position in Vericel Corp in Q1 2025 and held it in 3 quarters.
  • Capital Research Global Investors's Vericel Corp position peaked at $36.3M in Q2 2025.
  • 273 funds tracked by Wall St. Rank held Vericel Corp as of Q4 2025.

Based on Capital Research Global Investors's 13F filing for Q4 2025, filed 11 Feb 2026.